Association of Ratio of EGFR by Cystatin C and Creatinine with Mortality in Heart Failure

Overview

Journal Kidney360

Specialty Nephrology

Date 2024 Feb 12

PMID 38345438

Authors

Bethany Roehm

Meredith McAdams

Jonathan Gordon

Justin L Grodin

S Susan Hedayati

Affiliations

Soon will be listed here.

References

Damman K, Valente M, Voors A, OConnor C, Van Veldhuisen D, Hillege H . Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J. 2013; 35(7):455-69. DOI: 10.1093/eurheartj/eht386. View

Inker L, Eneanya N, Coresh J, Tighiouart H, Wang D, Sang Y . New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med. 2021; 385(19):1737-1749. PMC: 8822996. DOI: 10.1056/NEJMoa2102953. View

Talha K, Pandey A, Fudim M, Butler J, Anker S, Khan M . Frailty and heart failure: State-of-the-art review. J Cachexia Sarcopenia Muscle. 2023; 14(5):1959-1972. PMC: 10570089. DOI: 10.1002/jcsm.13306. View

Levey A, Inker L . Assessment of Glomerular Filtration Rate in Health and Disease: A State of the Art Review. Clin Pharmacol Ther. 2017; 102(3):405-419. DOI: 10.1002/cpt.729. View

Barreto E, Poyant J, Coville H, Dierkhising R, Kennedy C, Gajic O . Validation of the sarcopenia index to assess muscle mass in the critically ill: A novel application of kidney function markers. Clin Nutr. 2018; 38(3):1362-1367. DOI: 10.1016/j.clnu.2018.05.031. View

Aaronson K, Stewart G, Pagani F, Stevenson L, Palardy M, McNamara D . Registry Evaluation of Vital Information for VADs in Ambulatory Life (REVIVAL): Rationale, design, baseline characteristics, and inclusion criteria performance. J Heart Lung Transplant. 2019; 39(1):7-15. PMC: 7328667. DOI: 10.1016/j.healun.2019.09.008. View

Pinsino A, Carey M, Husain S, Mohan S, Radhakrishnan J, Jennings D . The Difference Between Cystatin C- and Creatinine-Based Estimated GFR in Heart Failure With Reduced Ejection Fraction: Insights From PARADIGM-HF. Am J Kidney Dis. 2023; 82(5):521-533. DOI: 10.1053/j.ajkd.2023.03.005. View

Kashani K, Frazee E, Kukralova L, Sarvottam K, Herasevich V, Young P . Evaluating Muscle Mass by Using Markers of Kidney Function: Development of the Sarcopenia Index. Crit Care Med. 2016; 45(1):e23-e29. DOI: 10.1097/CCM.0000000000002013. View

Ivey-Miranda J, Inker L, Griffin M, Rao V, Maulion C, Turner J . Cystatin C and Muscle Mass in Patients With Heart Failure. J Card Fail. 2020; 27(1):48-56. PMC: 8672303. DOI: 10.1016/j.cardfail.2020.07.013. View

10.

Farrington D, Surapaneni A, Matsushita K, Seegmiller J, Coresh J, Grams M . Discrepancies between Cystatin C-Based and Creatinine-Based eGFR. Clin J Am Soc Nephrol. 2023; 18(9):1143-1152. PMC: 10564370. DOI: 10.2215/CJN.0000000000000217. View